News
A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...
Groundbreaking new research from Princeton University and the Simons Foundation has pinpointed four distinct subtypes of ...
Annexon offers speculative upside with Tanruprubart, targeting Guillain-Barré Syndrome's unmet needs. Click here to read my ...
Schizophrenia can be broken down into brain structure and gut health subtypes, which can be used for targeted treatment.
FDA conducted a postmarketing observational study that assessed the risk of GBS following vaccination with the two companies' RSV prefusion F protein vaccines using Medicare claims data from May ...
Guillain Barre Syndrome is a rare nerve disorder where the immune system attacks the peripheral nervous system. Fatality tally, due to GBS in Maharashtra, has risen to three with a caseload of 130 ...
Group B Strep is an infection that can be dangerous to newborns. WebMD shows you how to help prevent it, and offers tips on what to do if your baby is diagnosed.
Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...
A new study by Zinnov and ProHance underscores the need for GBS leaders to implement robust productivity frameworks for organizational success.
Guillain-Barré Syndrome (GBS) poses a diagnostic challenge due to its misleading symptoms, the lack of a definitive test, and similarities with other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results